Internal Medicine · 2000 · 29 citations · 27 references
MedicineCardiologyClinical CardiologyLipid BiochemistryPreventive CardiologyCardiac BiomarkersCardiac Risk AssessmentCardiovascular AssessmentCardiovascular DiseaseCoronary Artery DiseaseIschemic Heart DiseaseAntithrombin FunctionCoronary Artery Stenosis AssessmentCoronary Stenosis AssessmentLipid Profile AnalysisLow-density Lipoprotein Cholesterol MeasurementPlasma Cholesterol LevelsPlasminogen ActivatorsPositive Predictive Value
OBJECTIVE: We designed the present study to evaluate the association of various lipid and fibrinolytic components with coronary artery stenosis with respect to the triglyceride (TG) level. METHODS: Levels of TG, remnant-like particle cholesterol (RLP-C), total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), lipoprotein-(a), uric acid, blood glucose, tissue plasminogen activator (t-PA), t-PA inhibitor type 1, antithrombin III, and protein C were measured in 208 patients who underwent diagnostic coronary angiograms. PATIENTS: Of these 208 patients, 59 were hypertriglyceridemic (150 mg/dl or higher) and 149 were normotriglyceridemic. RESULTS: Both LDL-C and HDL-C showed significant differences between patients with and those without coronary artery stenosis in both hypertriglyceridemic and normotriglyceridemic patient subgroups. However, RLP-C showed a significant difference in the normotriglyceridemic patient subgroup (p=0.012) but not in the hypertriglyceridemic patient subgroup (p=0.736). CONCLUSION: Our current retrospective study disclosed that RLP-C levels are closely associated with coronary artery stenosis in patients with normal TG levels.
27
Austen Wg, Je. Edwards, RL Frye et al. · Circulation · 1975 · 3.3K citations · Full text
Medicine, Cardiology, Surgery +17